Skip to main content Back to Top
Advertisement

5/26/2016

Hydroxyzine Hydrochloride Injection

Products Affected - Description

    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 50 mg/mL, 10 mL multiple dose vial, 25 count, NDC 00517-5610-25
    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 50 mg/mL, 2 mL vial, 25 count, NDC 00517-5602-25

Reason for the Shortage

    • American Regent has hydroxyzine injection on shortage due to manufacturing delays.
    • American Regent is the sole supplier of hydroxyzine injection.

Available Products

    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 25 mg/mL, 1 mL vial, 25 count, NDC 00517-4201-25
    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 50 mg/mL, 1 mL vial, 25 count, NDC 00517-5601-25

Estimated Resupply Dates

    • American Regent has hydroxyzine 50 mg/mL 2 mL and 10 mL vials on back order and the company cannot estimate a release date.

Updated

Updated May 26, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 9, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins